INTRODUCTION
The Hedgehog (Hh) signaling network controls key aspects of metazoan development including cell fate, tissue patterning, and proliferation (1, 2) . Hh signaling perturbations cause developmental defects such as cyclopia and polydactyly, and increased signaling is implicated in cancers including those of the skin, brain, and breast (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) .
In the absence of an Hh ligand, Smoothened (SMO) is functionally inhibited by the Hh receptor Patched-1 (Ptch1) or Patched-2 (Ptch2). SMO inhibition leads to the repression of target gene expression by production of transcriptional repressor forms of the Gli transcription factors. In the presence of an Hh ligand, Hh will bind to Ptch1 or Ptch2 with the aid of a co-receptor system composed of Commodo, Brother of Commodo, and Gas1 to promote release of SMO inhibition (14, 15) . SMO activation allows production of the transcriptional activator forms of the Gli transcription factors, which promote target gene expression (16) .
SMO is homologous with seven-pass transmembrane G protein (heterotrimeric guanine nucleotide-binding protein)-coupled receptors (GPCRs), but data supporting G protein coupling in vivo have been lacking. Genetic analyses in Drosophila have demonstrated that Ga i -protein coupling is essential for canonical Smo-mediated Hh signal transduction (17) . Smo GPCR function in Drosophila demonstrates that signaling varies slightly from its vertebrate counterpart. Ogden and colleagues have shown that in Drosophila, the presence of Hh promotes recruitment of Ga i to a complex with Smo, a process that is facilitated by the kinesin-related protein Cos2. Once in a complex with Smo, Ga i activation leads to a reduction in intracellular adenosine 3′,5′-monophosphate (cAMP) concentration and presumably reduces protein kinase A activation (17) . In cultured mammalian cells, SMO can couple with several Ga subunits including the pertussis toxin (PTX)-sensitive Ga i1 , Ga i2 , Ga i3 , and Ga o (17) (18) (19) (20) (21) . PTX functions by adenosine diphosphateribosylating Ga i/o proteins to prevent GPCR coupling. It blocks pigment aggregation in Xenopus laevis melanophores, an SMO-mediated process, suggesting an SMO-Ga i interaction (22) . Whether SMO can function as a GPCR in vivo in mammals has not been demonstrated.
We have previously shown that Cre-recombinase dependent expression of constitutively active SMO (hereinafter SmoM2 c ) in mammary epithelial cells promotes proliferation in a paracrine or juxtacrine manner and that SmoM2 c -overexpressing cells show evidence of Hh pathway activation (13, 23) . Here, we provide evidence that SmoM2 c can function as a GPCR that requires the heterotrimeric G protein Ga i2 and that SmoM2 c -induced proliferation appears to occur independently of Gli1 or Gli2 transcription factor function.
RESULTS

In vivo treatment with PTX suggests involvement of one or more PTX-sensitive G proteins
To determine whether SMO might promote mammary epithelial cell proliferation in vivo through one or more PTX-sensitive Ga i proteins, we induced the expression of SmoM2 c , as well as recombination of the Cre-dependent dual-fluorescence reporter mT-mG, through intraductal injection of adenovirusexpressing Cre recombinase (ad-Cre) (23, 24) . Ad-Cre-mediated recombination of SmoM2 c in a subset of ductal epithelial cells was indicated by enhanced green fluorescent protein (EGFP) expression from the recombined mT-mG allele, whereas SmoM2 c -negative cells lacking recombination remained tdTomato-positive (see Materials and Methods for details). Adenovirus-lacZ (ad-lacZ) was injected in the contralateral mammary gland as a negative control. We subsequently treated mice with PTX or phosphate-buffered saline (PBS) vehicle control and evaluated proliferation by bromodeoxyuridine (BrdU) incorporation.
Control mammary glands infected with ad-lacZ and treated with PBS showed proliferation rates consistent with those of mammary glands from normal adult virgin mice (Fig. 1A) . In contralateral ad-Cre-infected, PBStreated mammary glands, SmoM2 c expression led to increased proliferation in SmoM2 c -negative cells (Fig. 1B) , consistent with previous results (23) . In contrast, PTX impaired the proliferative response to SmoM2 c such that there was no difference between ad-lacZ-and ad-Cre-treated animals ( Fig. 1, C and D, PTX group). Quantification of BrdU incorporation for each group is displayed in Fig. 1E .
PTX attenuates SMO-induced proliferation ex vivo
Because PTX treatment in vivo may cause systemic changes that could confound the analysis, we sought to determine whether PTX could act directly on the mammary gland using cultured explants. Mammary gland explants derived from 5-week-old mT-mG/SmoM2 c ;MMTV-Cre and mT-mG/SmoM2 c ;+ (Cre-negative) littermates were maintained in organ culture ex vivo and treated with either PBS or PTX and pulsed with BrdU. In this system, SmoM2 c expression was achieved through a genetic cross to an MMTV-Cre transgenic mouse that expresses Cre recombinase in a mammary-selective manner under the control of the mouse mammary tumor virus (MMTV) long terminal repeat promoter, rather than by ad-Cre injection. The control mT-mG/SmoM2 c ;+ explants treated with PBS showed proliferation rates expected for ducts in a 5-week-old gland (Fig. 1F) . Explants with MMTV-Cre-mediated SmoM2 c recombination (as indicated by EGFP fluorescence) displayed increased proliferation (Fig. 1G) . Consistent with the results of our in vivo experiment, PTX abolished (Fig. 1, H and I) , demonstrating that the effects of PTX were not due to a systemic influence on the mammary gland. The quantification of BrdU incorporation for each group is displayed in Fig. 1J .
PTX does not affect ovarian hormone-or pregnancy-induced mammary epithelial cell proliferation
To evaluate whether PTX could block steroid hormone-induced proliferation, we induced mammary epithelial cell proliferation in wild-type female mice with combined estrogen (E 2 ) and progesterone (P 4 ) treatment (compared to sesame oil vehicle) and concurrently administered either PTX or PBS vehicle control.
Treatment with E 2 and P 4 in conjunction with PBS led to an increase in cell division compared with sesame oil-treated mice ( Fig. 2A compared to Fig. 2B ). This increase in proliferation was not blocked by PTX (Fig. 2 , C to E, and table S1).
To test PTX specificity for SmoM2 c -induced proliferation further, we treated pregnant mice with either PBS vehicle control or PTX. Consistent with the steroid hormone treatment, pregnancy-induced proliferation was unaffected by PBS ( Fig. 2F ) and was not blocked by PTX (Fig. 2G) . The quantification of BrdU incorporation is displayed in Fig. 2H and table S1.
Genes encoding PTX-sensitive Ga i subunits are expressed in mammary epithelial cells, and the expression of the gene encoding Ga i1 is specifically increased by SmoM2 ;+ mice were used as the "wild-type" control to identify genes that were differentially regulated in response to SmoM2 c expression. Overall, mRNAs encoding 15 Ga subunits were detectably expressed, including all known PTX-sensitive Ga subunits. Of these, the mRNA encoding the PTX-sensitive Ga i1 subunit was the only transcript that showed increased expression as a consequence of SmoM2 c expression (Fig. 3A) . The expression of genes encoding PTX-sensitive Ga i (Ga i1 , Ga i2 , and Ga i3 ) subunits was validated by quantitative reverse transcription polymerase chain reaction (qRT-PCR) using two independent primer sets for each gene (Fig. 3B) . These expression data suggested that Ga i1 was the most likely candidate for mediating the effects of SmoM2 c but did not rule out Ga i2 and Ga i3 because the genes encoding these Ga subunits were the most highly expressed of those encoding PTX-sensitive Ga subunits.
SmoM2
c -induced mammary gland proliferation requires PTX-sensitive Ga i2
To test the hypothesis that at least one of these Ga i subunits mediates In ad-lacZ-injected negative control mammary glands carrying wild-type alleles of Ga i1 , Ga i2 , and Ga i3 , baseline proliferation was low, consistent with that of an adult wild-type mouse (Fig. 4A) . Conversely, in positive control glands, SmoM2 c expression in the presence of all three wild-type Ga i alleles increased mammary gland proliferation (Fig. 4B) , as expected. In the ad-lacZ control group, Ga i1 disruption did not alter baseline proliferation (Fig. 4C) , although heterozygous deletion of one Ga i1 allele led to an unexpected increase in proliferation ( fig. S2 ). Contrary to our hypothesis, homozygous Ga i1 disruption failed to attenuate mice intraductally infected with ad-Cre and ad-lacZ with the Gli1 and Gli2 antagonist GANT61 (25) . As a positive control for GANT61 activity, we tested its specificity in vivo using the uterine artificially induced decidual response, which requires Hh signaling (26) . The difference in the decidual response was quantified by measuring the weight ratio of the decidual horn (left horn) to the control horn (right horn).
Vehicle-treated mice experienced a robust response on the horn that underwent decidual trauma (left horn) compared to the unstimulated horn (right horn) (Fig. 5A ). GANT61 completely blocked the decidual response such that there was no difference between the decidual and control horns (Fig. 5, A and B). To determine whether Gli transcription factor target genes were affected by GANT61 treatment, we performed qRT-PCR analysis and found that GANT61 reduced the expression of Hh pathway autoregulated genes Ptch1, Gli1, Gli2, and Hhip (Fig. 5C ), thereby confirming the specificity of GANT61.
We next analyzed mammary gland proliferation in SmoM2 c mice treated with vehicle and GANT61. In mice that received vehicle, proliferation was increased in ad-lacZ compared to ad-Cre groups, as expected ( Pathway analysis of genes that showed increased expression only in recombined EGFP cells indicated enhanced expression of some genes involved in cytoskeletal regulation and in G protein signaling ( fig. S4 ). Furthermore, we found that genes involved in Hh and Notch signaling pathways showed increased expression only in recombined EGFP cells, consistent with our previously published results (23) . Additionally, genes in the Wnt signaling/planar cell polarity pathways, which may participate in the SmoM2 c -promoted alveolar budding phenotypes observed here and/or in previous findings (23) , also showed increased expression. SmoM2 c expression caused the decreased expression of hormone receptor genes (Esr1, Pgr, and Prlr) and increased the expression of genes associated with mammary epithelial cell differentiation (Csn1s2a, Csn2, and Btn2a2).
To gain insight into the response of unrecombined tdTomato mammary epithelial cells to recombined EGFP cells, we analyzed the genes and pathways that showed increased expression only in the tdTomato cells (yellow-colored genes) as well as those that showed decreased expression in recombined EGFP cells and increased expression in unrecombined tdTomato cells (magentacolored genes). This gene level and pathway analysis revealed that genes encoding collagens showed increased expression in unrecombined tdTomato cells in addition to decreased expression in recombined EGFP cells and increased expression in unrecombined tdTomato cells ( fig. S4 ).
Recombined EGFP cells had a large number of genes with a marked increase in expression of those encoding factors involved in axon guidance, which included multiple signaling pathways such as Slit-Robo signaling (Robo1 and Srgap1), ephrin-ephrin receptor signaling (Epha7, Ephb1, and Ephb7), semaphorin-plexin signaling (Plxna1), and neurotrophic signaling (Ntrk3, Ntf4, and Bdnf) ( fig. S4 ). We found that the expression of the genes encoding the receptors for these different axon guidance pathways showed increased expression in the responding unrecombined tdTomato cells and, although not differentially regulated, genes encoding downstream effectors such as Ras and RhoA signaling axes were expressed in unrecombined tdTomato cells. Analysis of genes encoding receptors that are not involved in axon guidance and that showed increased expression in the unrecombined tdTomato cells revealed many membranebound receptors that could be signaling within this population of cells to promote cell proliferation. These receptors include the Ga i -coupled GPCRencoding genes Lpar1 and Slpr3, the Ga s -coupled receptor-encoding gene Calcrl, and the GPCR-encoding gene Ptgfr ( fig. S4 ).
DISCUSSION
We report here that SMO-induced paracrine stimulation of mammary epithelial cell proliferation was abolished by PTX, as well as by Ga i2 disruption in SmoM2 c -expressing cells themselves, revealing a cell-autonomous requirement for Ga i2 . These data indicated that Ga i2 was necessary to mediate SMO-induced proliferation and that no other Ga i subunit compensated for its loss. Further, our GANT61 results suggested that mammary gland proliferation as a consequence of SmoM2 c expression did not depend on Gli1 or Gli2 transcription factor function.
PTX-sensitive
Our current findings agree with previous publications that suggest that SmoM2 couples with and activates Ga i2 , and with studies that demonstrate that Ga i2 is one of the Ga i subunits required for Shh-induced proliferation in cerebellar granular neuronal precursor cells (19, 21) . Additionally, our results fit with data demonstrating that SmoM2-mediated Hh signaling, which is blocked by PTX, is rescued by expression of a mutant Ga i2 that fails to hydrolyze guanosine triphosphate (19) , supporting the notion that this is indeed a Ga i2 -mediated process. However, unlike previous findings in cere- (20, 27) .
The dual-fluorescence mT-mG reporter allowed us to separate recombined EGFP cells expressing SmoM2 c from unrecombined tdTomato cells and to assess the unique transcriptional changes elicited by SmoM2 c expression that may account for the paracrine stimulation of proliferation observed in this model. Our gene expression data demonstrated that Ga i1 showed increased expression as a consequence of SmoM2 c expression in mammary epithelial cells. We speculate that a potential explanation may be due to increased expression of genes encoding different adenylyl cyclases as a result of SmoM2 c overexpression. Increased Ga i1 expression may be part of a negative feedback loop to modulate adenylyl cyclase activity. One interesting idea is that Gli transcription factors may be acting as transcriptional activators of Ga i1 ; however, the Ga i1 promoter lacks Gli binding sites and Ga i1 has not been identified as a putative Gli transcriptional target in a previous analysis of Shh targets during neural patterning (28) . These findings, coupled with the lack of useful antibodies to perform chromatin immunoprecipitation analysis, make Ga i1 as a Gli target both unlikely and a difficult hypothesis to test.
Our Ingenuity Pathway Analysis identified candidate gene networks and signaling pathways (namely, Hh, Notch, and G protein signaling) modulated by SmoM2 c expression in EGFP cells. Of these, genes encoding axon guidance molecules, which are associated with tissue morphogenesis, cell adhesion, and proliferation in the mammary gland, were differentially regulated (mainly they showed increased expression) as a consequence of tdTomato cells. Previous data from our laboratory suggest that SmoM2 overexpression in the mammary gland results in altered proliferation, disrupted histoarchitecture, and increased branching and budding of the ductal epithelium (23) . These alterations in ductal growth and morphology could potentially be explained by disruption of axon guidance molecules, specifically those affecting Slit-Robo receptor biology, ephrin signaling, and semaphorin signaling as has been previously demonstrated by others (29) (30) (31) . It would be interesting to compare the molecular basis of the branching and budding phenotypes observed in our SmoM2 model to the molecular events transpiring during alveologenesis to determine whether similar mechanisms are used by mammary epithelial cells. Given the differential regulation of hormone receptorencoding genes and genes normally expressed during alveolar differentiation in recombined EGFP cells ( fig. S4 ), as well as the increased expression of stem cell-associated genes in unrecombined tdTomato cells, it would not be surprising that alveologenesis-like differentiation processes are being used because of altered SMO activity in the mammary gland. In unrecombined tdTomato cells, increased expression of genes encoding several collagens was observed, which is consistent with previously observed changes in the extracellular matrix of SmoM2 c ;MMTV-Cre mouse mammary glands, which include an increase in periductal collagen deposition (23) . We hypothesize that this change could be due to the disruption in the luminal and myoepithelial layers that occurs with SmoM2 c overexpression (23) . The gene level and pathway analysis has allowed us to identify potential ligand-receptor interactions between recombined EGFP and unrecombined tdTomato cells, specifically those of the Wnt pathway and axon guidance processes. The expression of Bdnf, Ntf4, and Pdgfa, which encode axon guidance signaling ligands, was increased in recombined EGFP cells, and the expression of Ntrk2 and Pdgfra/b, which encode the receptors for these ligands, was increased in unrecombined tdTomato cells. These receptors signal through Ras/Raf/MAPK (mitogen-activated protein kinase) pathways, which are mitogenic, and thus, these results could explain the paracrine-mediated increase in proliferation. Such pathways could be functionally tested in the future with small-molecule inhibitors such as cabozantinib, sunitinib, or telatinib.
One caveat in our analysis includes the strategy that was used to isolate the unrecombined tdTomato mammary epithelial cells. We used the mT-mG reporter to isolate the unrecombined cells from the mT-mG/ SmoM2 c ;MMTV-Cre population, which includes not only all proliferating tdTomato cells but also those nonproliferating cells, which make up the majority of the cell population. This strategy might dilute transcripts that were expressed exclusively in the proliferating cells and prevent us from identifying the key signaling pathways activated in these dividing cells.
Our study provides insight that could be translated toward the development of better therapeutic anticancer agents that target wild-type and mutant SMO and perhaps partially addresses the issue of resistance seen with several of these SMO antagonists. If human SMO activation in cancers uses a G protein pathway simultaneously with, or independently of, GLI signaling to drive tumor behavior, then SMO antagonists screened solely on the basis of their ability to block GLI-mediated transcriptional activation may be suboptimal. It would be useful to assess Hh signaling in clinical specimens from patients who suffer from cancers displaying aberrant Hh signaling such as basal cell carcinomas or medulloblastomas that do not respond to current SMO antagonists to determine whether the G protein pathway is in fact activated. Of relevance in breast cancer, the data presented in this study may be particularly relevant to the 70% of noninvasive ductal carcinoma in situ and 30% of invasive breast cancers that display ectopic expression of SMO (13) . SMO expression in these breast cancers may contribute to the maintenance of subclonal heterogeneity required to promote non-cellautonomous proliferation in tumors, a hypothesis confirmed in models of breast cancer (32) . Collectively, our data support a model of paracrinemediated interactions in the context of normal tissue development as well as tumor maintenance and suggest that Hh-driven proliferative phenotypes in other organs and structures should be reevaluated with respect to a potential role for Ga i .
MATERIALS AND METHODS
Animal models
Mouse lines Gt(ROSA)26Sor 
Adenovirus microinjection
Ad5-CMV-Cre and Ad5-CMV-LacZ stocks were diluted to 1.0 × 10 10 PFU/ml in sterile Ringer's solution and supplemented with bromophenol blue as a marker dye. This dilution was made immediately before performing intraductal injection and maintained on ice to ensure virus stability. Inguinal and thoracic mammary glands of 6-week-old mice were injected with 10 ml of Ad5-CMV-Cre virus on the right-side mammary glands or Ad5-CMV-LacZ virus on the left side as described previously (23) . Mammary glands were harvested 2 weeks after injection, fixed in cold 4% paraformaldehyde (PFA), and processed for immunostaining.
In vivo administration of PTX PTX was purchased from Sigma-Aldrich and reconstituted in PBS at 100 ng/ml. BrdU was purchased from Sigma-Aldrich and was reconstituted in PBS at 25 mg/ml. Six-week-old mT-mG/SmoM2 c mice (injected with ad-lacZ/ad-Cre) were treated with an intraperitoneal injection of PTX (300 ng/day) for two consecutive days. On the third day, the mice were pulsed with BrdU (250 mg/kg) administered intraperitoneally for 2 hours and euthanized. Mammary glands were removed, fixed in cold 4% PFA for 3 hours, and processed for immunostaining.
GANT61 administration in vivo
Gli1 and Gli2 antagonist (GANT61) was a gift from R. Toftgård. GANT61 was dissolved in a corn oil and ethanol mixture (4:1 ratio) at a concentration of 25 mg/ml. Six-week-old mT-mG/SmoM2 c mice (injected with ad-lacZ/ ad-Cre) were treated with a subcutaneous injection of GANT61 (50 mg/kg) for three consecutive days. On the third day, the mice were pulsed with BrdU (250 mg/kg) administered intraperitoneally for 2 hours and euthanized.
Ex vivo organ culture
Mammary gland tissues from 5-week-old mT-mG/SmoM2 c ;MMTV-Cre and wild-type control littermates were harvested and placed in Waymouth's medium (Invitrogen) to keep glands moist (35) . Glands were then spread on a petri dish to obtain 3-mm punch biopsies containing epithelium and stroma with the aid of a fluorescence dissection stereoscope (Leica MZ16 F). Biopsies were then spread on Dacron mesh (Millipore) and incubated on the surface of Waymouth's medium supplemented with Hepes (20 mM), hydrocortisone (100 ng/ml), insulin (5 mg/ml), aldosterone (100 ng/ml), gentamicin (50 mg/ml), and antibiotic-antimycotic (1×) at 37°C for 2 days. Fresh medium with and without PTX (100 ng/ml) was added 1 day after initial culture, tissue biopsies were harvested 24 hours afterward and fixed in 4% PFA, and 3-mm tissue sections were cut for immunofluorescence staining. All samples are representative of pooled biological replicates from three experiments.
E 2 and P 4 -and pregnancy-induced proliferation
Eight-to 9-week-old nulliparous, wild-type mice were injected with a single interscapular subcutaneous injection of E 2 (1 mg) and P 4 (1 mg) or sesame oil vehicle control on treatment day 1 (36) . Mice were also treated intraperitoneally with either PTX or PBS on treatment days 1 and 2. Mice were pulsed with BrdU on day 3 and sacrificed to harvest and process tissues for histology. As a further control, we examined the effect of PTX treatment on pregnancy-induced proliferation. For timed matings, 9-week-old wild-type female mice were exposed to soiled bedding from male mice for 3 days. Thereafter, a male was added on the fourth day. Day 1 of pregnancy was determined by visualization of a vaginal mucus plug. Animals were treated with PTX or PBS on pregnancy days 4 and 5 and sacrificed on day 6 of pregnancy. Samples analyzed for the ovarian hormone and pregnancy PTX studies are representative of pooled biological replicates from five experiments in each study and were sampled randomly for the treatments received. ;MMTV-Cre (recombined; expressing EGFP) mammary epithelial cells were FACS-sorted using an Aria II instrument (BD Biosciences). Total RNA was isolated from the different mammary epithelial cell populations using a Qiagen miRNeasy kit according to the manufacturer's instructions (Qiagen).
RNA sequencing
Purified double-stranded complementary DNA (cDNA) was generated from 10 ng of total RNA and amplified using both 3′ poly(A) selection and random priming throughout the transcriptome. Samples were quantified using the NanoDrop ND-1000 spectrophotometer (Thermo Scientific) and Qubit 2.0 DNA quantitation assay (Invitrogen). Each sample (3 mg) was sheared using the S2 Focused-ultrasonicator (Covaris) following the Encore NGS Library System 1 protocol (NuGEN) to obtain a final library insert size of 150 to 200 base pairs. The sheared samples were quantified using the NanoDrop ND-1000 spectrophotometer and Qubit 2.0 DNA quantitation assay. The fragment sizes were confirmed on a Bioanalyzer (Agilent Technologies) to verify proper shearing. A doublestranded DNA library was created using 200 ng of sheared, double-stranded cDNA, which prepares the fragments for hybridization onto a flowcell. This was achieved by first creating blunt-ended fragments and ligating unique adapters to the ends. The ligated products were amplified using 15 cycles of PCR. The resulting libraries were quantitated using the NanoDrop ND-1000 spectrophotometer. Library fragment size was assessed using the Bioanalyzer DNA 1000 chip (Agilent Technologies). A quantitative PCR (qPCR) quantitation was performed on the libraries to determine the concentration of adapter-ligated fragments using an iCycler iQ Real-Time PCR Detection System (Bio-Rad) and Library Quantification Kit (KAPA Biosystems).
With the concentration from the qPCR machine above, 6 pM of library was loaded onto a flowcell and amplified by bridge amplification using the cBot machine (Illumina). A paired-end 100-cycle run was used to sequence the flowcell on a HiSeq 2000 Sequencing System (Illumina).
The raw paired-end RNA-seq reads were aligned to mouse (mm9) genomes using STAR version 2.3.0e (38) with default settings and filtered for uniquely mapped reads. An average of about 80% of reads could be mapped; about 40 to 50% of reads were mapped to exonic regions. The normalization was performed by computing a normalization factor for each sample and each gene. A median value of the normalization factors of all the genes for each sample was selected as the normalization factor for the given sample. The normalized counts for each gene of a given sample were then transformed by asinh (39) ;MMTV-Cre (EGFP)] was performed using DESeq (40) by assuming that the sequencing count data follow a negative binomial distribution. P values were generated for each gene, and q values were generated from these P values using the Benjamini-Hochberg procedure (41) . Each group contained four biological replicates that consisted of pooled sorted cells from five experiments. After alignment, a gene-level quality control analysis was performed using hierarchical clustering. Samples that were extreme outliers from their respective treatment groups were excluded from subsequent analysis.
The differential gene expression analysis among the three sorted cell populations described above was used to tabulate genes with increased or decreased expression in only recombined EFGP or unrecombined tdTomato mammary epithelial cells relative to wild-type tdTomato mammary epithelial cells, differentially expressed genes shared between recombined EGFP and unrecombined tdTomato mammary epithelial cells, genes with decreased expression in the recombined EFGP cells but increased expression in the unrecombined tdTomato cells, or vice versa. Furthermore, we tabulated the genes that had no difference in expression in either recombined EFGP or unrecombined tdTomato mammary epithelial cells relative to wildtype tdTomato mammary epithelial cells. The criteria for inclusion of differentially expressed genes in any of the different classifications were a pairwise fold change of twofold or greater between a pair of sorted cell populations (for example, either recombined EGFP or unrecombined tdTomato cells compared to wild-type tdTomato cells) and a q value as determined by the Benjamini-Hochberg method of 0.05 or less. Considering both increased and decreased expression and no change in the two comparisons between recombined EGFP and wild-type tdTomato cells or unrecombined tdTomato and wild-type tdTomato cells, there were eight total possible classes of differentially expressed genes (excluding the null class that is unchanged in both comparisons). These different classifications of differentially regulated genes were uploaded into Ingenuity Pathway Analysis in two different groups for analysis. The groups we focused on consisted of (i) genes with increased and decreased expression only in recombined EGFP cells compared to wild-type tdTomato mammary epithelial cells, (ii) genes with increased and decreased expression only in unrecombined tdTomato cells compared to wild-type tdTomato mammary epithelial cells, and (iii) genes with decreased expression in recombined EGFP cells and increased expression in unrecombined tdTomato cells.
Quantitative reverse transcription polymerase chain reaction
To evaluate the expression of mRNAs encoding Ga subunits, total RNA was isolated from FACS-sorted cells as described above. cDNA was synthesized using NuGEN's Whole Transcriptome Ovation kit per the manufacturer's instructions. TaqMan primer and probe sets and reagents were obtained from Applied Biosystems (assay ID numbers are found in table S4). qRT-PCR was performed using two independent primer and probe sets. Data were normalized to b-actin, and relative quantification was used to evaluate the changes in expression of mRNAs encoding ;MMTV-Cre (EGFP) samples. All qRT-PCR assays were run using Applied Biosystems 7500 Fast Real-time PCR system. Analysis was conducted using the DC t method, and box plots with scatters were generated for visually representing data. Each group contained five biological replicates with each one having three technical replicates, which were averaged for analysis.
Immunohistochemistry
Sections (3 mm) were deparaffinized and rehydrated into PBS through a series of graded ethanols. To retrieve antigens, slides were heated in tris-EDTA buffer at a pH of 9.0 under pressurized conditions using a decloaker (Biocare Medical). BrdU (1:200, Abcam, #ab6326) and GFP (1:250, Abcam, #ab290) were diluted in 1.5% goat serum and 8% Mouse on Mouse (M.O.M.) (Vector Laboratories) protein concentrate for background staining reduction. Slides were incubated with primary antibodies at 4°C overnight. Slides were washed in PBS supplemented with 0.04% Tween 20 and incubated with Alexa Fluor-conjugated secondary antibodies (1:500, Life Technologies, #A11007 and #A11008) for 1 hour at room temperature.
Image acquisition and processing
For in vivo and ex vivo PTX experiments, imaging was performed using a Zeiss Axioskop 2 (Zeiss Instruments) plus fluorescence microscope and AxioVision 4.8 (Zeiss MicroImaging). For in vivo experiments, the percentage of BrdU incorporation was assessed by counting ten 40× fields representative of two glands per mouse. For the ex vivo experiment, seven representative 40× fields were counted from each organ culture biopsy per group. BrdU incorporation was counted using MetaMorph imaging software (Molecular Devices), and the investigator performing the counting was blinded as to the sample or group until the quantification was completed.
Statistical analysis
Statistical analysis of the effects of PTX and GANT61 on in vivo BrdU incorporation was calculated using Wilcoxon signed rank test. Differences in BrdU incorporation as a result of PTX ex vivo treatment or ovarian hormone-and pregnancy-induced proliferation were assessed with Wilcoxon rank-sum test. DESeq (RNA-seq data) and Wilcoxon rank-sum (qRT-PCR data) tests were used to test for differences in gene expression. Differences in BrdU incorporation in the genetic experiments were tested using Wilcoxon signed rank and rank-sum tests.
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